Our observations stand in contrast to these findings, as 34.3% of our angiosarcomas exhibited unequivocal TRPS1 labeling, while in nine cases (25.7%), TRPS1 expression was deemed uncertain. This evidence concerns the gene TRPS1 and angiosarcoma.